This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier Unveils Updated 8th Edition Of Rutherford's Vascular Surgery At 2014 Vascular Annual Meeting In Boston

PHILADELPHIA, June 3, 2014 /PRNewswire/ --

Two-volume reference is a 'living textbook,' updated with the most current procedures and techniques and includes access to the enhanced eBook through Elsevier's Expert Consult    

Elsevier, a world-leading provider of scientific, technical and medical information products and services, will unveil Rutherford's Vascular Surgery, 8 th Edition, a comprehensive two-volume reference, at the 2014 Vascular Annual Meeting in Boston, June 5 - 7.

The thoroughly revised reference contains the most current evidence-based vascular and endovascular procedures and techniques available today, thanks to contributions made by more than 280 vascular surgery experts. Elsevier will hold a Q&A session with the authors at its booth (#1105) on June 5 from 5:30-6:30 p.m.

The Society for Vascular Surgery, which hosts the Vascular Annual Meeting, has collaborated with Elsevier to publish this new edition of Rutherford's Vascular Surgery. The new edition is now available, and Elsevier is currently accepting orders.

" Rutherford ' s Vascular Surgery is the definitive reference for physicians who care for patients with vascular disease," said Jack L. Cronenwett, M.D., Professor of Surgery, Dartmouth-Hitchcock Medical Center, and the book's Co-Editor. "Many expert authors joined forces to integrate information on medical, endovascular and surgical treatments with updated insights on diagnostic techniques, decision-making and vascular biology."

This new edition of Rutherford ' s Vascular Surgery features 164 chapters organized into 27 sections, including basic science, clinical and laboratory evaluation, vascular imaging, atherosclerotic risk factors, perioperative care, bleeding and clotting, arterial occlusive and aneurysmal diseases, venous thromboembolism, and venous insufficiency and occlusion. New to the 8th Edition are chapters on dialysis catheters, endovascular management of aortic branches, along with updated coverage of medical management, endovascular procedures, open surgical techniques, and all modalities of vascular imaging.

"The new edition and e-format makes it fast and easy for physicians to find techniques and approaches for endovascular applications, vascular access, imaging and non-operative management," said K. Wayne Johnston, M.D., FRCSC, Professor of Surgery, University of Toronto, and the book's Co-Editor. "Full-color layout and images, plus annotated key references and bibliographies, help clinicians understand clinical and operative findings and master operative technique."

A significant highlight of the 8th Edition is the introduction of an enhanced eBook available on the newly re-launched Elsevier's Expert Consult platform. The e-book offers search, rich media and social and community features. Physicians can interact with content through multimedia features, self-assessment questions, references, abstracts, and procedural videos. An editorial board will insert new content into relevant chapters to make this a "living textbook."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,090.68 +4.05 0.02%
S&P 500 1,989.99 +2.98 0.15%
NASDAQ 4,476.0680 +2.3710 0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs